Video
Pharmacy Times spoke with spinal muscular atrophy (SMA) patient Nick Sinagra about his treatment journey and his experiences with 2 different SMA treatments.
Pharmacy Times spoke with spinal muscular atrophy (SMA) patient Nick Sinagra about his treatment journey and his experiences with 2 different SMA treatments.
Sinagra discussed his experiences using SPINRAZA and Evrysdi, the challenges of living with SMA, what pharmacists need to understand about counseling patients with SMA, and what he hopes to see for the future of the rare disease.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa